Smith Nicholas Conrad 4
4 · Alto Neuroscience, Inc. · Filed Apr 1, 2024
Insider Transaction Report
Form 4
Smith Nicholas Conrad
CHIEF FINANCIAL OFFICER & CBO
Transactions
- Purchase
Common Stock
2024-03-28$15.80/sh+1,600$25,280→ 22,316 total - Purchase
Common Stock
2024-03-28$16.56/sh+4,550$75,348→ 26,866 total